๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase I study of pyrazofurin

โœ Scribed by Philip A. Salem; Gerald P. Bodey; Michael A. Burgess; William K. Murphy; Emil J. Freireich

Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
312 KB
Volume
40
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase i-ii study of maytansine utilizi
A phase i-ii study of maytansine utilizing a weekly schedule
โœ Roman Franklin; Michael K. Samson; Roberto J. Fraile; Hakam Abu-Zahra; Robert O' ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 428 KB ๐Ÿ‘ 2 views

Maytansine, a new ansa macrolide antitumor antibiotic, was administered to a total of 107 patients in a Phase 1-11 study. Dose-limiting toxic reactions which occurred at 0.75-1.0 mg/M' in both Phase I and I1 were neurologic and consisted primarily of lethargylweakness (a debilitation syndrome) and p

Phase I study of L-alanosine (NSC 15353)
Phase I study of L-alanosine (NSC 15353)
โœ Michael A. Goldsmith; Takao Ohnuma; Melvin Spigelman; Ezra M. Greenspan; James F ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 234 KB
Limited phase I study of morphine-3-gluc
Limited phase I study of morphine-3-glucuronide
โœ Richard T. Penson; Simon P. Joel; Simon Clark; Anna Gloyne; Maurice L. Slevin ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 171 KB

The toxicity of morphine-3-glucuronide (M3G) has been investigated in an open, uncontrolled, single-blinded, single dose study over a limited range of doses. Three cohorts each of three healthy volunteers received 7.5, 15, and 30 mg/70 kg intravenous (IV) M3G. Blood sampling was undertaken for the f